Title |
Epithelioid Sarcoma: Opportunities for Biology-Driven Targeted Therapy
|
---|---|
Published in |
Frontiers in oncology, August 2015
|
DOI | 10.3389/fonc.2015.00186 |
Pubmed ID | |
Authors |
Jonathan Noujaim, Khin Thway, Zia Bajwa, Ayeza Bajwa, Robert G. Maki, Robin L. Jones, Charles Keller |
Abstract |
Epithelioid sarcoma (ES) is a soft tissue sarcoma of children and young adults for which the preferred treatment for localized disease is wide surgical resection. Medical management is to a great extent undefined, and therefore for patients with regional and distal metastases, the development of targeted therapies is greatly desired. In this review, we will summarize clinically relevant biomarkers (e.g., SMARCB1, CA125, dysadherin, and others) with respect to targeted therapeutic opportunities. We will also examine the role of EGFR, mTOR, and polykinase inhibitors (e.g., sunitinib) in the management of local and disseminated disease. Toward building a consortium of pharmaceutical, academic, and non-profit collaborators, we will discuss the state of resources for investigating ES with respect to cell line resources, tissue banks, and registries so that a roadmap can be developed toward effective biology-driven therapies. |
X Demographics
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 1 | 25% |
Unknown | 3 | 75% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 4 | 100% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Italy | 1 | 2% |
Germany | 1 | 2% |
Unknown | 51 | 96% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 10 | 19% |
Student > Doctoral Student | 6 | 11% |
Other | 5 | 9% |
Student > Bachelor | 4 | 8% |
Student > Ph. D. Student | 4 | 8% |
Other | 9 | 17% |
Unknown | 15 | 28% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 21 | 40% |
Biochemistry, Genetics and Molecular Biology | 4 | 8% |
Agricultural and Biological Sciences | 3 | 6% |
Mathematics | 1 | 2% |
Decision Sciences | 1 | 2% |
Other | 3 | 6% |
Unknown | 20 | 38% |